Regulatory Focus Target pharmaceutical and biotech firms seeking FDA cGMP, GLP, and GCP compliance; position Complya as a specialized QA and regulatory affairs partner to accelerate audit readiness and reduce regulatory risk.

Acquisition Footprint Leverage past acquisition by PharmaLex to approach mid-market players undergoing consolidation or seeking expanded US regulatory presence; emphasize integration capabilities and expanded regulatory coverage.

Small Firm Advantage Capitalize on being a smaller firm with lean teams (11-50 employees) to offer highly personalized, flexible engagement models, rapid turnaround times, and cost-efficient compliance solutions for startups and virtual organizations.

Digital footprint Promote cloud-native tech stack and modernized delivery methods (MongoDB Atlas, AWS, Google Cloud, HubSpot) to appeal to digitally mature clients prioritizing scalable, secure, and auditable compliance programs.

Growth Opportunities Identify potential upsell in GMP/GLP/GCP training, gap assessments, internal audits, and documentation optimization for contract manufacturers and CROs seeking to shorten timelines and raise quality Bar in regulatory submissions.